As the U.S. hits 200,000 COVID-19 deaths, Trump tells an Ohio rally the coronavirus 'affects virtually nobody'


The U.S. passed yet another "grim milestone" in its COVID-19 pandemic Monday night, Reuters notes, with at least 200,000 Americans dead from the new coronavirus and an average of nearly 1,000 more dying each day. As "the country blew past estimate after estimate" of COVID-19 deaths, Politico's pandemic newsletter said Monday night, "the term 'grim milestone' in headlines became so routine that we banned it."
COVID-19 deaths are rising again in the U.S. after a four-week decline, with Texas and Florida leading the news fatalities, Reuters reports, and the University of Washington's Institute for Health Metrics and Evaluation now predicts 300,000 deaths by Dec. 9 and 378,000 by the end of 2020 if current trends continue. The IHME's first projection of U.S. coronavirus deaths, issued March 16, topped out at 162,000. The U.S., with about 4 percent of the world's population, has 20 percent of its recorded COVID-19 deaths.
At a rally in Dayton, Ohio, on Monday night, President Trump assured his admirers the virus isn't really that bad, noting that it mostly kills "elderly people" and people with "other problems," adding, "It affects virtually nobody."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
According to CDC data, more than 70 percent of U.S. COVID-19 deaths are among people older than 65, which means about 60,000 of the dead were 65 and younger. And a lot of the estimated millions of U.S. "long-haulers" who did not die from COVID-19 are still grappling with a wide array of health problems, some of the potentially serious.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Road trip: New England’s maple syrup season
Feature New England is serving up maple syrup in delicious and unexpected ways
By The Week US Published
-
Music Reviews: Mdou Moctar, Panda Bear, and Tate McRae
Feature “Tears of Injustice,” “Sinister Grift,” and “So Close to What”
By The Week US Published
-
What's at stake in the Mahmoud Khalil deportation fight?
Talking Points Vague accusations and First Amendment concerns
By Joel Mathis, The Week US Published
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
By Peter Weber, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published